相关实验视频

Updated: Jun 29, 2025

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.3K

阿尔茨海默病在纳米,微型和宏观尺度上的计算模型

Éléonore Chamberland1,2, Seyedadel Moravveji1,2, Nicolas Doyon1,2

  • 1Centre de Recherche CERVO, Institut Universitaire de Santé Mentale de Québec, Québec, QC, Canada.

Frontiers in neuroinformatics
|April 8, 2024
PubMed
概括

这项研究介绍了阿尔茨海默病 (AD) 进展的多尺度数学模型,集成蛋白质,细胞和器官动态. 该模型旨在改善对AD的理解并确定治疗点.

关键词:
在这里,APOEOE是APOE.阿尔茨海默病的疾病阿尔茨海默病的疾病.氨基βββββββββββββββββββββββββ复杂的生物系统复杂的生物系统.数学模型是数学模型.常规微分方程 常规微分方程个性化的方法,个性化的方法.蛋白质是一种蛋白质.

更多相关视频

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.2K
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

7.9K

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183